Geneva, April 28 -- International Clinical Trials Registry received information related to the study (NCT07536763) titled 'Arterial Vascular Effects of Estetrol-drospirenone Combined Oral Contraceptive Pill' on April 12.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Dr. Hang Wun Raymond Li
Condition:
Contraception
Intervention:
Drug: Estetrol-drospirenone
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: July 2026
Target Sample Size: 98
To know more, visit https://clinicaltrials.gov/study/NCT07536763
Published by HT Digital Content Services with permission from Hea...